Abstract
Pulmonary fibrosis causes high morbidity and mortality in affected individuals. Recently, we showed that parenteral or intratracheal administration of a peptide derived from endostatin, called E4, prevents and ameliorates fibrosis using different models of dermal and pulmonary disease. No marketed orally delivered peptide drugs are currently available for progressive pulmonary fibrosis; however oral delivery of drugs is the preferred route for treating most chronic diseases. Thus, we investigated whether oral administration of E4 peptide exerted anti-fibrotic activity in a murine pulmonary fibrosis model. Bleomycin (1.2mU/g body weight) was intratracheally administrated to male 6-8-week-old C57BL/6J mice. E4 peptide (20, 10, 5, and 1 μg/mouse) or scrambled control peptide (20 μg/mouse) was orally administered on the same day as bleomycin. In some experiments, E4 peptide (10 and 5 μg/mouse) was orally administered three times on days 0, 3, and 6 post-bleomycin treatment. Lungs were harvested on day 21 for histological analysis and hydroxyproline assay. Histological analysis and hydroxyproline assay revealed that bleomycin successfully induced pulmonary fibrosis, and that 20 μg of oral E4 peptide ameliorated the fibrosis. The low...Continue Reading
References
Jan 24, 1997·Cell·M S O'ReillyJ Folkman
May 19, 2000·Arthritis and Rheumatism·K M McKownA E Postlethwaite
Nov 3, 2009·Drug Discovery Today·Patrick VliegheMichel Khrestchatisky
Nov 19, 2009·The Journal of Clinical Investigation·Angélica M SantosEllen Puré
May 18, 2011·Autoimmunity Reviews·Isabel AlmeidaCarlos Vasconcelos
Jun 1, 2012·Science Translational Medicine·Yukie YamaguchiCarol A Feghali-Bostwick
Jan 10, 2014·Skin Pharmacology and Physiology·E ProkschS Oesser
Apr 22, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Ivana V Yang, David A Schwartz
May 13, 2014·Expert Opinion on Drug Delivery·Alice L SmartAbdul W Basit
May 20, 2014·The New England Journal of Medicine·Luca RicheldiUNKNOWN INPULSIS Trial Investigators
May 20, 2014·The New England Journal of Medicine·Talmadge E KingUNKNOWN ASCEND Study Group
Oct 15, 2014·ACS Medicinal Chemistry Letters·Timothy A HillDavid P Fairlie
Jan 22, 2015·Drugs·Esther S Kim, Gillian M Keating
Jan 24, 2015·Molecular Pharmaceutics·Jie WangAbdul W Basit
Jun 13, 2015·Drugs·Gillian M Keating
Citations
Feb 13, 2016·Frontiers in Pharmacology·Sylvie Ricard-Blum, Sylvain D Vallet
Dec 23, 2017·Journal of Scleroderma and Related Disorders·Sara M GarrettCarol Feghali-Bostwick
Dec 5, 2017·Biological & Pharmaceutical Bulletin·Muneyoshi OkadaHideyuki Yamawaki
Jun 26, 2018·International Journal of Molecular Sciences·Katsuyuki TanabeJun Wada
Apr 9, 2020·Food & Function·Ana Lemus-ConejoSergio Montserrat-de la Paz
May 14, 2020·Nutritional Neuroscience·Ana Lemus-ConejoSergio Montserrat-de la Paz
Mar 13, 2018·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Muneyoshi Okada, Hideyuki Yamawaki
Oct 8, 2020·American Journal of Physiology. Lung Cellular and Molecular Physiology·Xinh-Xinh NguyenCarol Feghali-Bostwick
Nov 15, 2017·Matrix Biology : Journal of the International Society for Matrix Biology·Sylvie Ricard-Blum, Sylvain D Vallet
Oct 2, 2021·Drug Delivery·Zequn ZhangGui Hu
Nov 7, 2021·Cell Biology and Toxicology·Shuchan LiHuifang Tang
Jul 21, 2020·Bioscience Reports·Xuguang XuLiusha Kong